Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

0.1814
-0.5374-74.76%
Post-market: 0.1719-0.0095-5.24%19:59 EDT
Volume:58.56M
Turnover:12.57M
Market Cap:5.68M
PE:-0.06
High:0.2299
Open:0.2240
Low:0.1569
Close:0.7188
52wk High:4.29
52wk Low:0.1569
Shares:31.31M
Float Shares:26.89M
Volume Ratio:49.36
T/O Rate:217.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1505
EPS(LYR):-5.7255
ROE:-1766.94%
ROA:-102.43%
PB:-0.05
PE(LYR):-0.03

Loading ...

Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities